mucos
epithelia
constitut
first
barrier
overcom
pathogen
infect
induct
protect
iga
locat
import
prevent
infect
achiev
differ
mucos
immun
strategi
lactic
acid
bacteria
test
last
year
live
vector
deliveri
antigen
mucos
site
promis
result
work
streptococcu
pneumonia
psaa
antigen
express
differ
speci
lactic
acid
bacteria
lactococcu
lacti
lactobacillu
casei
lactobacillu
plantarum
lactobacillu
helveticu
nasal
inocul
mice
abil
induc
system
igg
serum
mucos
iga
saliva
nasal
bronchial
wash
antipsaa
antibodi
determin
immun
l
lacti
induc
low
level
iga
igg
possibl
low
amount
psaa
express
strain
short
persist
nasal
mucosa
three
lactobacilli
persist
nasal
mucosa
day
produc
similar
amount
psaa
protein
ng
per
cfu
howev
l
plantarum
l
helveticu
elicit
highest
antibodi
respons
iga
igg
vaccin
recombin
lactobacilli
recombin
l
lacti
led
decreas
pneumonia
recoveri
nasal
mucosa
upon
colon
challeng
result
confirm
certain
lactobacillu
strain
intrins
properti
make
suitabl
candid
mucos
vaccin
experi
fig
express
psaa
differ
lab
strain
western
blot
analysi
protein
extract
show
constitut
express
psaa
l
lacti
l
l
psaa
l
casei
l
c
psaa
l
plantarum
l
p
psaa
l
helveticu
l
h
psaa
psaa
band
point
arrow
lysat
respect
control
strain
carri
empti
vector
also
shown
figur
b
lysat
cell
recombin
lab
load
onto
sdspage
transfer
nitrocellulos
membran
concentr
ng
rpsaa
use
refer
estim
amount
psaa
shown
panel
ng
l
lacti
ng
l
casei
ng
l
plantarum
ng
l
helveticu
c
supernat
recov
treatment
differ
strain
lyzosym
arrow
point
psaa
band
streptococcu
pneumonia
major
agent
pneumonia
around
world
caus
one
million
death
per
year
mainli
develop
countri
high
cost
medic
care
appear
new
clinic
isol
multidrug
resist
led
search
effici
new
vaccin
prevent
pneumococc
infect
sinc
pathogen
enter
host
respiratori
mucosa
vaccin
induc
product
protect
secretori
iga
site
well
system
igg
antibodi
would
desir
pneumococc
surfac
antigen
psaa
membraneanchor
virul
factor
possibl
involv
mn
zn
transport
predict
crystal
structur
psaa
delet
mutant
display
low
abil
adher
mucos
cell
therefor
less
pathogen
characterist
may
due
differ
modul
pneumococc
adhesin
caus
absenc
mn
zn
cell
psaa
conserv
among
describ
pneumonia
serotyp
also
immunogen
make
good
candid
vaccin
formul
fact
antibodi
produc
psaa
nasal
immun
use
cholera
toxin
b
subunit
adjuv
shown
protect
mice
nasopharyng
colon
pneumonia
protect
increas
coadministr
psaa
pneumococc
surfac
protein
pspa
anoth
pneumococc
virul
factor
anoth
approach
oral
immun
mice
psaa
encapsul
microspher
induc
product
igg
iga
result
protect
lung
colon
septicemia
five
differ
pneumonia
strain
live
bacteri
vaccin
vector
extens
studi
mucos
immun
prevent
differ
infecti
diseas
among
lactic
acid
bacteria
lab
especi
attract
sinc
microorgan
present
gastrointestin
mucosa
healthi
individu
wide
use
dietari
product
possess
gra
gener
recogn
safe
statu
characterist
share
attenu
pathogen
deriv
live
vector
due
possibl
revers
attenu
phenotyp
could
danger
mainli
immunocompromis
individu
interact
lab
immun
system
potenti
antigen
carrier
subject
number
recent
publish
studi
differ
strain
rout
inocul
evalu
use
fragment
c
tetanu
toxin
ttfc
far
best
character
antigen
express
lab
approach
result
protect
tetanu
toxin
lethal
challeng
antigen
like
protect
antigen
bacillu
anthraci
protein
human
papilloma
viru
antigen
brucella
abortu
env
protein
hiv
protein
streptococcu
pyogen
spike
glycoprotein
gastroenter
coronaviru
express
lab
potenti
vaccin
associ
diseas
current
evalu
case
immun
l
lacti
express
hiv
env
protein
protein
streptococcu
pyogen
protect
observ
use
adequ
anim
model
case
vitro
neutral
effect
antibodi
observ
use
induc
express
system
base
lactos
operon
lactobacillu
casei
express
psaa
pspa
antigen
pneumonia
either
intracellularli
secret
cultur
media
recombin
l
casei
test
potenti
antipneumococc
vaccin
nasal
immun
mice
far
could
detect
signific
level
antipsaa
iga
igg
unpublish
data
failur
stimul
product
antibodi
may
result
lack
psaa
pspa
express
recombin
l
casei
nasal
immun
due
absenc
induc
host
mucosa
reason
decid
use
system
allow
constitut
express
psaa
differ
lab
strain
work
recombin
lactococcu
lacti
lactobacillu
casei
lactobacillu
plantarum
lactobacillu
helveticu
express
psaa
evalu
abil
induc
system
mucos
immun
respons
nasal
immun
mice
nasal
colon
streptococcu
pneumonia
mice
also
analyz
bacteri
strain
growth
condit
l
casei
formerli
atcc
l
plantarum
kindli
provid
dr
k
thompsom
food
agricultur
microbiolog
research
divis
depart
agricultur
northern
ireland
uk
l
helveticu
atcc
routin
grown
mr
medium
difco
c
without
shake
l
lacti
grown
medium
difco
contain
glucos
c
without
shake
plate
bacteria
perform
respect
media
agar
select
transform
mgml
erythromycin
use
media
vector
kindli
provid
dr
lothar
steidler
depart
molecular
biolog
flander
interunivers
institut
biotechnolog
ghent
univers
belgium
contain
lactococc
constitut
promot
signal
sequenc
bp
gene
encod
psaa
pneumonia
serotyp
strain
st
instituto
adolpho
lutz
paulo
sp
brazil
amplifi
pcipsaa
plasmid
pcr
use
follow
oligonucleotid
psaaiforw
atg
cat
cga
tat
cag
cta
gcg
gaa
aaa
aag
psaairev
cca
agc
ttt
tat
ttt
gcc
aat
cct
tca
pcr
perform
use
taq
dna
polymeras
invitrogen
mm
deoxynucleosid
triphosph
pmol
primer
pcr
amplif
condit
follow
c
min
cycl
c
c
c
min
c
min
final
extens
pcr
product
clone
pgemt
vector
promega
sequenc
confirm
one
clone
chosen
prepar
psaa
fragment
follow
pgemtpsaa
plasmid
digest
hindiii
treat
klenow
polymeras
invitrogen
gener
blunt
end
digest
nsii
result
fragment
clone
previous
digest
bamhi
treat
klenow
dna
polymeras
invitrogen
gener
blunt
end
digest
psti
provid
protrud
end
compat
nsii
end
insert
nucleic
acid
manipul
gener
clone
procedur
perform
accord
laboratori
manual
prepar
compet
l
lacti
overnight
cultur
dilut
contain
glycin
incub
c
od
reach
bacteria
collect
centrifug
g
min
c
pellet
wash
two
time
saccharos
glycerol
vv
bacteria
resuspend
solut
electropor
immedi
kept
c
use
l
lacti
electropor
ligat
mixtur
kv
u
mf
cm
cuvett
use
biorad
genepuls
biorad
life
scienc
research
product
ca
usa
plasmid
isol
l
lacti
use
electropor
lactobacillu
strain
electropor
l
casei
carri
previous
describ
protocol
use
lactobacillu
strain
except
electropor
buffer
threefold
concentr
antibiot
resist
l
lacti
lactobacillu
clone
screen
presenc
insert
interest
pcr
use
specif
primer
describ
posit
clone
frozen
mr
contain
glycerol
c
isol
l
lacti
lactobacillu
clone
grown
overnight
mr
respect
cultur
ml
collect
centrifug
g
min
bacteri
pellet
suspend
ml
mm
trisehcl
ph
cell
suspens
transfer
ml
tube
contain
volum
glass
bead
lysat
prepar
vigor
shake
beadbeat
biospec
bartlesvil
ok
usa
four
cycl
maxim
speed
lysat
centrifug
g
min
supernat
maintain
c
analysi
quantif
psaa
cultur
grown
od
reach
cfu
valu
cultur
determin
extract
correspond
cfu
analyz
western
blot
concentr
curv
load
gel
use
recombin
psaa
express
purifi
e
coli
analysi
psaa
cell
wall
bacteria
incub
mgml
lysozym
mm
glucos
mm
trisehcl
ph
mm
edta
c
min
suspens
centrifug
g
min
supernat
collect
protein
extract
supernat
fraction
sdspage
electrotransf
nitrocellulos
membran
use
mini
protean
ii
equip
biorad
life
scienc
research
product
ca
usa
mous
polyclon
antipsaa
antiserum
develop
recombin
pneumonia
psaa
strain
st
express
e
coli
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
chemic
st
loui
mo
usa
use
accord
manufactur
instruct
detect
perform
use
chemiluminesc
ecl
kit
ge
healthcar
sixto
eightweekold
femal
mice
five
per
group
receiv
either
recombin
bacteria
express
psaa
respect
control
bacteria
harbor
empti
vector
addit
control
group
receiv
salin
lab
strain
grown
cultur
reach
od
bacteria
collect
centrifug
g
min
room
temperatur
wash
salin
suspend
cell
ml
nasal
immun
mice
anesthet
mixtur
xilazin
ketamin
ml
salin
suspens
contain
cell
inocul
nostril
help
micropipett
day
ten
day
last
booster
mice
bled
retrorbit
plexu
collect
saliva
pilocarpin
solut
inject
intraperiton
nasal
bronchial
wash
perform
describ
elsewher
use
ml
ml
salin
respect
antipsaa
antibodi
detect
sera
saliva
nasal
bronchial
wash
enzymelink
immunoabsorb
assay
elisa
previous
describ
use
rpsaa
purifi
e
coli
coat
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antimous
iga
sigma
chemic
st
loui
mo
usa
titer
defin
last
dilut
absorb
nm
reach
mainten
lab
strain
harbor
plasmid
respiratori
mucosa
analyz
day
nasal
inocul
bacteria
perform
nasal
bronchial
wash
group
four
anim
day
inocul
day
dilut
wash
plate
mr
contain
mgml
erythromycin
coloni
count
h
incub
c
sixto
eightweekold
mice
per
group
immun
describ
individu
serum
pool
saliva
collect
analysi
antipsaa
igg
iga
respect
fifteen
day
last
inocul
anim
anesthet
ml
suspens
contain
cfu
streptococcu
pneumonia
strain
serotyp
inocul
nasal
day
nasal
wash
perform
use
ml
salin
serial
dilut
sampl
plate
blood
agar
contain
mgml
gentamicin
alphahemolyt
coloni
count
incub
plate
h
c
consid
volum
recov
represent
graphic
statist
analysi
log
appli
valu
recoveri
cfu
consid
cfu
differ
antibodi
titer
analyz
mann
whitney
u
test
p
consid
significantli
differ
test
use
analysi
pneumonia
colon
p
consid
significantli
differ
psaa
gene
clone
vector
psti
site
produc
fusion
truncat
signal
peptid
carri
vector
psaa
sequenc
fig
control
constitut
promot
ligat
product
use
transform
l
lacti
express
psaa
analyz
western
blot
cell
lysat
l
lacti
carri
construct
vector
show
express
protein
around
kda
react
antipsaa
antibodi
present
extract
cell
carri
empti
vector
fig
recombin
plasmid
isol
l
lacti
use
transform
differ
lactobacillu
strain
western
blot
analysi
protein
extract
erythromycin
resist
coloni
show
express
psaa
l
casei
l
plantarum
l
helveticu
psaa
band
observ
respect
strain
carri
empti
vector
fig
use
recombin
psaa
refer
could
calcul
l
lacti
cfu
express
approxim
ng
psaa
amount
synthes
differ
lactobacillu
strain
ng
l
plantarum
ng
l
casei
ng
l
helveticu
psaa
fig
psaa
detect
concentr
cultur
media
clone
indic
secret
protein
occur
data
shown
howev
analysi
supernat
obtain
incub
cell
lysozym
show
least
part
protein
direct
cell
wall
fig
moreov
incub
whole
cell
mous
polyclon
antipsaa
follow
incub
antimous
iggperoxidas
conjug
reveal
opd
h
posit
reaction
observ
lab
express
psaa
indic
least
part
protein
expos
outsid
cell
contrast
neg
reaction
observ
lab
strain
carri
empti
vector
data
shown
recombin
lab
use
nasal
immun
mice
observ
fig
nasal
inocul
l
casei
l
plantarum
l
helveticu
express
psaa
induc
specif
antipsaa
iga
pool
saliva
detect
level
antipsaa
iga
antibodi
observ
saliva
collect
anim
receiv
l
lacti
express
psaa
lab
strain
carri
vector
salin
anim
subject
nasal
bronchial
wash
analysi
presenc
iga
respiratori
tract
sampl
highest
iga
titer
could
observ
anim
group
receiv
either
l
plantarum
l
helveticu
express
psaa
fig
b
mean
significantli
differ
group
receiv
salin
p
p
respect
respect
control
carri
empti
vector
p
p
respect
anim
receiv
l
casei
express
psaa
display
detect
level
iga
nasal
bronchial
mucosa
group
singl
anim
show
high
iga
titer
mean
group
significantli
differ
control
salin
l
casei
carri
empti
vector
p
group
receiv
l
lacti
express
psaa
display
low
level
antipsaa
iga
nasal
wash
even
detect
level
bronchial
wash
fig
b
mean
valu
differ
salin
group
l
lacti
group
p
analysi
sera
collect
anim
reveal
anim
display
highest
level
antipsaa
iga
also
display
highest
level
antipsaa
igg
show
correl
product
two
class
antibodi
data
shown
analysi
pneumonia
colon
experi
perform
use
anim
per
group
challeng
induct
antipsaa
igg
evalu
serum
collect
anim
produc
similar
result
previou
experi
fig
nasal
administr
recombin
l
plantarum
l
helveticu
express
psaa
led
induct
highest
titer
antipsaa
igg
serum
wherea
low
level
antipsaa
igg
could
observ
sera
anim
receiv
recombin
l
lacti
l
casei
fig
statist
analysi
show
result
obtain
group
receiv
l
plantarum
psaa
l
helveticu
psaa
significantli
higher
result
obtain
group
receiv
salin
p
l
plantarum
p
l
helveticu
respect
control
strain
carri
vector
p
level
antipsaa
igg
induc
l
lacti
psaa
l
casei
psaa
significantli
differ
level
found
salin
group
p
comparison
control
strain
carri
empti
vector
show
differ
found
l
lacti
p
wherea
l
casei
psaa
induc
higher
level
antipsaa
igg
compar
l
casei
p
fifteen
day
last
dose
anim
challeng
pneumonia
strain
result
coloni
count
fig
show
signific
reduct
pneumonia
colon
l
plantarum
psaa
l
helveticu
psaa
group
compar
anim
receiv
salin
p
l
plantarum
p
l
helveticu
compar
respect
control
signific
differ
observ
l
plantarum
p
administr
l
helveticu
psaa
led
signific
reduct
pneumonia
colon
relat
l
p
administr
l
lacti
psaa
induc
signific
reduct
pneumonia
colon
either
compar
salin
group
l
lacti
group
p
interestingli
administr
l
casei
led
inhibit
pneumonia
colon
compar
salin
group
p
express
psaa
strain
produc
much
stronger
effect
p
howev
result
obtain
l
casei
psaa
group
significantli
differ
result
obtain
l
casei
group
p
lab
strain
carri
empti
vector
induc
signific
reduct
pneumonia
colon
compar
salin
group
differ
observ
abil
induc
antipsaa
antibodi
well
differ
pneumonia
colon
led
us
analyz
possibl
correl
perman
recombin
strain
mice
respiratori
mucosa
lab
strain
could
recov
nasal
wash
day
almost
total
anim
analyz
none
lab
recov
nasal
wash
day
bronchial
wash
test
day
nasal
inocul
respect
strain
carri
empti
vector
produc
similar
result
show
psaa
express
exert
effect
bacteria
perman
mice
respiratori
mucosa
data
shown
protein
extract
l
lacti
recov
day
lactobacillu
strain
recov
day
test
express
psaa
three
coloni
strain
grown
overnight
protein
extract
analyz
western
blot
recov
coloni
test
still
abl
express
psaa
vitro
data
shown
sever
strategi
induc
mucos
immun
respons
pneumonia
antigen
current
test
one
strategi
use
lab
live
vector
deliveri
specif
antigen
mucos
surfac
due
adhes
epithelium
claim
adjuv
properti
order
circumv
possibl
bacteri
host
depend
effect
could
compromis
success
design
live
vector
mucos
vaccin
express
psaa
protein
pneumonia
l
casei
cect
l
plantarum
l
helveticu
atcc
well
model
lab
l
lacti
strain
fusion
signal
sequenc
recombin
psaa
protein
direct
cell
wall
four
lab
assay
protein
detect
cultur
supernat
previou
report
express
psaa
fusion
leader
sequenc
l
casei
cell
wall
proteinas
prtp
also
result
local
protein
cell
wall
secret
cultur
media
sinc
sequenc
specifi
psaa
coval
anchor
cell
surfac
natur
streptococc
host
absent
construct
seem
protein
particular
retain
cell
wall
differ
bacteria
recombin
lab
inocul
nasal
rout
abl
induc
differ
level
specif
antipsaa
iga
igg
mice
fig
l
plantarum
l
helveticu
turn
better
develop
mucos
system
antipsaa
immun
respons
l
casei
l
lacti
pool
saliva
l
casei
psaa
group
display
iga
induct
similar
found
l
plantarum
psaa
l
helveticu
psaa
group
fig
howev
nasal
bronchial
wash
individu
anim
l
casei
psaa
group
analyz
display
low
even
detect
level
iga
one
anim
produc
high
titer
antipsaa
iga
fig
b
high
titer
individu
may
caus
antipsaa
iga
observ
pool
saliva
l
casei
psaa
group
fig
sinc
l
casei
express
amount
psaa
l
plantarum
l
helveticu
also
recov
mice
nasal
mucosa
period
differ
observ
among
l
casei
lactobacilli
may
reflect
differ
intrins
adjuv
potenti
anoth
studi
shaw
collabor
shown
l
plantarum
ncimb
express
ttfc
produc
better
result
oral
immun
compar
l
casei
case
l
plantarum
persist
day
mice
gastrointestin
tract
wherea
l
casei
remain
h
inabl
l
lacti
express
psaa
significantli
induc
serum
igg
secret
iga
nasal
inocul
could
explain
low
level
express
strain
compar
lactobacilli
addit
observ
lactococci
carri
express
vector
remain
mice
nasal
mucosa
day
inocul
lactobacilli
could
detect
day
later
nasal
inocul
mice
l
lacti
psaa
exert
effect
pneumonia
colon
comparison
inocul
salin
l
lacti
carri
empti
vector
fig
hand
colon
pneumonia
significantli
reduc
mice
immun
l
helveticu
psaa
compar
anim
receiv
salin
l
helveticu
signific
decreas
pneumonia
colon
also
observ
group
receiv
l
plantarum
psaa
relat
group
receiv
salin
relat
group
receiv
l
plantarum
case
possibl
inhibit
effect
relat
strain
may
take
place
howev
import
notic
simpli
inocul
l
plantarum
strain
carri
empti
vector
suffici
caus
decreas
pneumonia
colon
interestingli
group
receiv
l
casei
carri
empti
vector
display
signific
reduct
pneumonia
colon
reduct
accentu
group
receiv
l
casei
psaa
sinc
administr
strain
induc
low
level
antipsaa
antibodi
mechan
may
caus
reduct
addit
although
correl
antibodi
induct
inhibit
pneumonia
colon
observ
compar
group
receiv
l
lacti
psaa
l
plantarum
psaa
l
helveticu
psaa
correl
alway
maintain
analyz
anim
individu
thu
induct
antipsaa
antibodi
may
one
factor
contribut
reduct
pneumonia
colon
nasal
immun
recombin
psaa
combin
pneumococc
protein
ctb
adjuv
well
oral
immun
microencapsul
psaa
ctb
abl
induc
mucos
system
antibodi
protect
mice
pneumonia
colon
studi
suggest
correl
antibodi
product
inhibit
colon
anoth
studi
use
colon
model
mice
nasal
inocul
pneumonia
result
mucos
antibodi
induct
associ
clearanc
bacteria
howev
correl
observ
amount
antibodi
detect
sera
mucosa
densiti
colon
individu
anim
addit
anim
impair
humor
immun
display
similar
densiti
durat
pneumonia
colon
normal
counterpart
author
discuss
compon
adapt
immun
respons
well
innat
immun
respons
may
main
contributor
pneumococc
clearanc
model
probiot
effect
certain
lactobacillu
strain
extens
studi
among
studi
l
casei
strain
shirota
shown
induc
cellular
immun
reduc
influenza
viru
titer
mice
respiratori
tract
administr
lactobacillu
fermentum
prior
pneumonia
challeng
led
increas
anti
pneumonia
antibodi
well
activ
macrophag
mice
lung
decreas
pneumonia
colon
although
regimen
administr
type
studi
differ
use
work
possibl
probiot
effect
lactobacillu
strain
use
rule
may
explain
reduct
pneumonia
colon
anim
immun
l
casei
result
support
use
lactobacilli
vaccin
purpos
experiment
prove
import
two
key
issu
design
live
vector
oral
vaccin
includ
amount
antigen
deliv
relat
express
system
strain
chosen
relev
immun
protocol
experi
stress
could
still
improv
perhap
achiev
stimul
immun
system
fewer
dose
effici
attempt
coadministr
lactobacilli
strain
express
pneumococc
antigen
pspa
current
evalu
